Price T Rowe Associates Inc Axsome Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 25,274 shares of AXSM stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,274
Previous 146,557
82.75%
Holding current value
$2.03 Million
Previous $11.7 Million
82.71%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37.1MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$362 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$301 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.2MShares$257 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$190 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$105 Million3.44% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.45B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...